Physician profile
Clarissa S Beiting
NPI 1407882913
$2,082.12
in general payments reported to CMS, 2019-2025
27 companies · $437 in 2025
The $437 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $57.13 · 2022: $266 · 2023: $884 · 2024: $324 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,420 · Education: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,420.33 |
| Education | $224.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $524.90 | 2019-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $429.86 | 2020-2025 | Aptima, Acessa Provu System, Novasure |
| Baxter Healthcare | $210.39 | 2025 | Tisseel |
| Abbvie INC. | $113.66 | 2022-2025 | Lo Loestrin Fe, Orilissa |
| Gynesonics, INC. | $107.67 | 2023-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Bayer Healthcare Pharmaceuticals INC. | $82.30 | 2022-2024 | |
| Axonics, INC. | $82.17 | 2022-2023 | Axonics |
| Coloplast Corp | $74.50 | 2025 | |
| Exeltis, USA INC. | $56.60 | 2022-2023 | Slynd |
| Pfizer INC. | $54.55 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $35.64 | 2023-2025 | Myfembree |
| Convatec INC. | $34.53 | 2023 | |
| Mayne Pharma Commercial LLC | $26.09 | 2022-2023 | |
| Ethicon US, LLC | $24.49 | 2024 | Dermabond Prineo |
| Therapeuticsmd, INC. | $24.15 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $23.65 | 2022 | |
| Ortho-Clinical Diagnostics, INC. | $22.42 | 2024 | |
| Shield Therapeutics INC | $20.33 | 2025 | |
| Agile Therapeutics, INC. | $17.45 | 2023 | Twirla |
| Lilly USA, LLC | $17.39 | 2025 | Zepbound |
| Arjo INC. | $15.92 | 2025 | |
| Organon LLC | $15.04 | 2024 | |
| Davol INC. | $14.94 | 2025 | Arista |
| Millicent US INC | $14.43 | 2025 | Intrarosa |
| Minerva Surgical, INC | $13.81 | 2023 | |
| Conmed Corporation | $13.53 | 2024 | Airseal |
| Avion Pharmaceuticals | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clarissa Beiting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.